Hidradenitis suppurativa perspectives during the COVID-19 pandemic

The COVID-19 pandemic created a new set of challenges regarding the care of patients with hidradenitis suppurativa (HS). Access to safe, timely medical care and the use of immunosuppressive therapy were central topics of concern for patients and providers. In addition, the incidence and severity of SARS-CoV-2 infection in patients with hidradenitis suppurativa were critical to examine during the evolving pandemic to provide recommendations for patients to make informed decisions about their disease and its management.
Source: Clinics in Dermatology - Category: Dermatology Authors: Source Type: research